Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_provenance.
- NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_assertion description "[Furthermore, in patient samples with HNC (n = 51) analyzed by quantitative MSP, NEFL promoter hypermethylation was associated with resistance to cisplatin-based chemotherapy [relative risk (RR), 3.045; 95% confidence interval (CI), 1.459-6.355; P = 0.007] and predicted diminished overall and disease-free survival for patients treated with cisplatin-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_provenance.
- NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_assertion evidence source_evidence_literature NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_provenance.
- NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_assertion SIO_000772 22246235 NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_provenance.
- NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_assertion wasDerivedFrom befree-20140225 NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_provenance.
- NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_assertion wasGeneratedBy ECO_0000203 NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP824606.RAotGKtuOuJ0hO_x1D6wlj8_ivn8DAYgZhy3NZwyjDlyM130_provenance.